Form 8.5 (EPT/RI)-Pollen Street Group Limited

Investec Bank plc disclosed dealings in Pollen Street Group Limited ordinary shares on 2 October 2026, reporting purchases of 879 shares at prices of 904–906 and sales of 5,000 shares at prices of 900–911; the filing does not specify a currency. Investec is Pollen Street’s joint broker, and the disclosure reported no related indemnity, dealing, options or derivatives arrangements.

Analysis

This is weak flow information, not a deal-probability signal. Investec disclosed activity while acting in a client-serving capacity as Pollen Street’s joint broker; the net sale therefore cannot be read as Investec taking a bearish proprietary view, nor as evidence that a client has lost confidence in the transaction. The disclosed share count is not interpretable for price impact without ordinary trading volume, free float and the relevant offer timetable. No derivative dealings or inducement arrangements were reported, but that does not establish the identity or motive of the trading client.

Near term, the only plausible effect is a minor technical overhang if further disclosures show persistent net selling and volume is thin. Over 1–3 months, deal terms, conditions and regulatory/timetable updates—not this isolated broker filing—should dominate POLN’s event risk. A delay, revised terms or failure to complete could reprice the shares; absent such developments, this filing alone provides no basis for changing deal odds. The contrarian point is that gross sales look more notable than purchases, but treating client facilitation as informed selling would overstate the signal. Reassess if repeated disclosures show materially larger net sales relative to daily volume or if offer-related terms change.

Key Decisions for Investors

• No trade on this disclosure alone; do not treat broker-facilitated net selling as a directional signal on Pollen Street or the offer.
• Monitor subsequent Rule 8 disclosures alongside POLN trading volume and the offer timetable. Escalate only if selling recurs at a meaningful share of turnover or coincides with adverse deal updates.
• For existing event-driven exposure, keep risk keyed to offer conditions, timing and terms; this filing does not independently justify changing the position.